Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism.

TIGAR Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer. J Biol Chem (2016) 0.78

Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice. Sci Rep (2016) 0.76

Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat Commun (2017) 0.76

NADPH: new oxygen for the ROS theory of aging. Oncotarget (2016) 0.75

In vivo evidence for long-term vascular remodeling resulting from chronic cerebral hypoperfusion in mice. J Cereb Blood Flow Metab (2016) 0.75

Oxygen sensors and neuronal adaptation to ischemia. Oncotarget (2017) 0.75

GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1α. Behav Brain Res (2016) 0.75

Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis. Cell Death Dis (2016) 0.75

Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD. Nat Rev Gastroenterol Hepatol (2017) 0.75

Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage. Mol Neurobiol (2016) 0.75

Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13

Small sample inference for fixed effects from restricted maximum likelihood. Biometrics (1997) 16.06

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell (2008) 13.49

TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell (2006) 11.85

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet (1999) 11.79

Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci (2003) 6.53

The science of stroke: mechanisms in search of treatments. Neuron (2010) 6.14

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell (2009) 5.91

Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene (2009) 5.81

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell (2006) 5.58

Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab (2001) 5.06

Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem (2004) 5.05

Oxygen sensing, homeostasis, and disease. N Engl J Med (2011) 5.03

Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke (1987) 4.97

Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci (2006) 4.51

Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron (2012) 4.48

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A (2006) 4.08

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet (2008) 3.94

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80

How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature (2012) 3.77

Metabolism and functions of glutathione in brain. Prog Neurobiol (2000) 3.74

p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol (2011) 3.70

Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes (2006) 3.69

Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab (2011) 3.57

In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A (1998) 3.53

Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods (1987) 3.47

Ischemic tolerance and endogenous neuroprotection. Trends Neurosci (2003) 3.44

The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol (2009) 3.40

Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet (2003) 3.36

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci (2004) 3.31

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 3.31

Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest (2006) 3.00

The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology (2007) 2.87

Cellular scaling rules for rodent brains. Proc Natl Acad Sci U S A (2006) 2.87

Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protoc (2007) 2.84

NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci (2009) 2.71

Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol (2006) 2.58

Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol (2011) 2.46

Synaptic energy use and supply. Neuron (2012) 2.40

The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science (2009) 2.35

Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Cancer Cell (2009) 2.15

Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov (2009) 2.10

Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature (2015) 2.01

Oxygen sensors at the crossroad of metabolism. Cell Metab (2009) 1.98

Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke (1997) 1.89

The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc (2009) 1.87

Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol (2008) 1.86

Updated energy budgets for neural computation in the neocortex and cerebellum. J Cereb Blood Flow Metab (2012) 1.81

Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J Cereb Blood Flow Metab (2010) 1.80

NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol (2011) 1.77

Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke (2000) 1.77

Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death. J Neurobiol (2002) 1.72

Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life (2012) 1.70

TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat Cell Biol (2013) 1.61

Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy. J Cereb Blood Flow Metab (1993) 1.60

Translational control of mitochondrial energy production mediates neuron morphogenesis. Cell Metab (2012) 1.55

Anatomy and functionality of leptomeningeal anastomoses: a review. Stroke (2003) 1.53

Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem (2002) 1.52

Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery (1996) 1.50

Metabolism of stromal and immune cells in health and disease. Nature (2014) 1.49

Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell (2014) 1.46

A roadmap for interpreting (13)C metabolite labeling patterns from cells. Curr Opin Biotechnol (2015) 1.44

Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology (2009) 1.37

PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling. Science (2014) 1.32

Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci (2013) 1.25

Culturing hippocampal and cortical neurons. Methods Cell Biol (2003) 1.22

Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J Pharmacol Exp Ther (1993) 1.22

New polyurethane-based material for vascular corrosion casting with improved physical and imaging characteristics. Microsc Res Tech (2006) 1.20

Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury. Gastroenterology (2009) 1.18

Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease. Nat Cell Biol (2014) 1.15

Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ (2012) 1.15

Increased brain size and glial cell number in CD81-null mice. J Comp Neurol (2002) 1.13

The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg Med Chem Lett (2002) 1.11

Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice. Antioxid Redox Signal (2011) 1.08

Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? J Cereb Blood Flow Metab (2012) 1.05

Therapeutic manipulation of the HIF hydroxylases. Antioxid Redox Signal (2010) 1.05

Response to 'comment on recent modeling studies of astrocyte-neuron metabolic interactions': much ado about nothing. J Cereb Blood Flow Metab (2011) 1.05

Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes. Trends Biochem Sci (2012) 1.04

Comment on recent modeling studies of astrocyte-neuron metabolic interactions. J Cereb Blood Flow Metab (2010) 1.02

Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol Biol Cell (2008) 1.01

Distribution of neurons in functional areas of the mouse cerebral cortex reveals quantitatively different cortical zones. Front Neuroanat (2013) 1.01

Prolyl 4-hydroxylases, master regulators of the hypoxia response. Acta Physiol (Oxf) (2013) 0.97

Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: the role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-kappa B. J Immunol (2010) 0.96

Characterisation of neuronal cell death in acute and delayed in vitro ischemia (oxygen-glucose deprivation) models. J Neurosci Methods (2010) 0.95

Oxygen sensing: a common crossroad in cancer and neurodegeneration. Curr Top Microbiol Immunol (2010) 0.95

A TIGAR-regulated metabolic pathway is critical for protection of brain ischemia. J Neurosci (2014) 0.95

Direct experimental occlusion of the distal middle cerebral artery induces high reproducibility of brain ischemia in mice. Exp Anim (2009) 0.93

O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth. Nat Commun (2015) 0.91

Strategies for the design and delivery of antisense oligonucleotides in central nervous system. Methods Enzymol (2000) 0.87

Brain energy metabolism in glutamate-receptor activation and excitotoxicity: role for APC/C-Cdh1 in the balance glycolysis/pentose phosphate pathway. Neurochem Int (2013) 0.87

Nerve growth factor and brain-derived neurotrophic factor but not granulocyte colony-stimulating factor, nimodipine and dizocilpine, require ATP for neuroprotective activity after oxygen-glucose deprivation of primary neurons. Brain Res (2012) 0.85

No oxygen? No problem! Intrinsic brain tolerance to hypoxia in vertebrates. J Exp Biol (2014) 0.85

Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism. Neurobiol Dis (2011) 0.85

Bioenergetic dysfunction in Huntington's disease human cybrids. Exp Neurol (2011) 0.84

Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice. J Physiol (2012) 0.82

Phosphorylation of the growth factors bFGF, NGF and BDNF: a prerequisite for their biological activity. Neurochem Int (2005) 0.81

The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models. Cell Metab (2014) 0.80

Endogenous level of TIGAR in brain is associated with vulnerability of neurons to ischemic injury. Neurosci Bull (2015) 0.77

Knockdown of glucose-6-phosphate dehydrogenase (G6PD) following cerebral ischemic reperfusion: the pros and cons. Neurochem Int (2012) 0.76